These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20869964)

  • 1. Development, validation and application of ELISAs for pharmacokinetic and HACA assessment of a chimeric anti-CD40 monoclonal antibody in human serum.
    Chowdhury F; Tutt AL; Chan C; Glennie M; Johnson PW
    J Immunol Methods; 2010 Dec; 363(1):1-8. PubMed ID: 20869964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validated detection of human anti-chimeric immune responses in serum of neuroblastoma patients treated with ch14.18/CHO.
    Siebert N; Eger C; Seidel D; Jüttner M; Lode HN
    J Immunol Methods; 2014 May; 407():108-15. PubMed ID: 24727144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validated detection of anti-GD2 antibody ch14.18/CHO in serum of neuroblastoma patients using anti-idiotype antibody ganglidiomab.
    Siebert N; Seidel D; Eger C; Brackrock D; Reker D; Schmidt M; Lode HN
    J Immunol Methods; 2013 Dec; 398-399():51-9. PubMed ID: 24055592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment with a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) for a patient with relapsed mantle cell lymphoma who developed a human anti-chimeric antibody.
    Maeda T; Yamada Y; Tawara M; Yamasaki R; Yakata Y; Tsutsumi C; Onimaru Y; Kamihira S; Tomonaga M
    Int J Hematol; 2001 Jul; 74(1):70-5. PubMed ID: 11530808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of an antibody capture and a cell capture ligand-binding assay to quantify a monoclonal therapeutic in serum.
    Spriggs F; Aggarwal P; Deng S; Soderstrom C; Donovan C
    Bioanalysis; 2011 Mar; 3(6):605-11. PubMed ID: 21417730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation and long term performance characteristics of a quantitative enzyme linked immunosorbent assay (ELISA) for human anti-PA IgG.
    Semenova VA; Schiffer J; Steward-Clark E; Soroka S; Schmidt DS; Brawner MM; Lyde F; Thompson R; Brown N; Foster L; Fox S; Patel N; Freeman AE; Quinn CP
    J Immunol Methods; 2012 Feb; 376(1-2):97-107. PubMed ID: 22197974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantitative human monoclonal antibody immunoassay using anti-idiotypic antibody as a membrane antigen surrogate with surface-plasmon-resonance detection.
    Wong RB; Lee AH; Rangan VS; Cheng KC
    Biotechnol Appl Biochem; 2009 May; 53(Pt 1):51-61. PubMed ID: 18680480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates.
    Stubenrauch K; Wessels U; Lenz H
    J Pharm Biomed Anal; 2009 May; 49(4):1003-8. PubMed ID: 19250787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple quantitative live cell and anti-idiotypic antibody based ELISA for humanized antibody directed to cell surface protein CD20.
    Hong K; Presta LG; Lu Y; Penn A; Adams C; Chuntharapai A; Yang J; Wong WL; Meng YG
    J Immunol Methods; 2004 Nov; 294(1-2):189-97. PubMed ID: 15604027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel homogeneous Biotin-digoxigenin based assay for the detection of human anti-therapeutic antibodies in autoimmune serum.
    Qiu ZJ; Ying Y; Fox M; Peng K; Lewin-Koh SC; Coleman D; Good J; Lowe J; Rahman A; Yang J; Jiang J; Quarmby V; Song A
    J Immunol Methods; 2010 Oct; 362(1-2):101-11. PubMed ID: 20868690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An anti-idiotopic antibody-based enzyme-linked immunosorbent assay for the quantification of the monoclonal anti-D BRAD-5.
    Austin EB; Smith LC; Walker RY
    Vox Sang; 2001 Apr; 80(3):179-83. PubMed ID: 11449958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic study of the effect of low pH acid treatment on anti-drug antibodies specific for a domain antibody therapeutic: Impact on drug tolerance, assay sensitivity and post-validation method assessment of ADA in clinical serum samples.
    Kavita U; Duo J; Crawford SM; Liu R; Valcin J; Gleason C; Dong H; Gadkari S; Dodge RW; Pillutla RC; DeSilva BS
    J Immunol Methods; 2017 Sep; 448():91-104. PubMed ID: 28625864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of murine anti-human Fab antibodies for use in an immunoassay for generic quantification of human Fab fragments in non-human serum samples including cynomolgus monkey samples.
    Stubenrauch K; Wessels U; Essig U; Kowalewsky F; Vogel R; Heinrich J
    J Pharm Biomed Anal; 2013 Jan; 72():208-15. PubMed ID: 23017233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodies.
    Stubenrauch K; Wessels U; Essig U; Vogel R; Schleypen J
    J Pharm Biomed Anal; 2010 Jun; 52(2):249-54. PubMed ID: 20083366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a standardized ELISA for the detection of soluble Fc-epsilon-RI in human serum.
    Lexmond W; der Mee Jv; Ruiter F; Platzer B; Stary G; Yen EH; Dehlink E; Nurko S; Fiebiger E
    J Immunol Methods; 2011 Oct; 373(1-2):192-9. PubMed ID: 21903095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of an ELISA for the determination of rituximab pharmacokinetics in clinical trials subjects.
    Hampson G; Ward TH; Cummings J; Bayne M; Tutt AL; Cragg MS; Dive C; Illidge TM
    J Immunol Methods; 2010 Aug; 360(1-2):30-8. PubMed ID: 20547164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Affinity Capture Elution (ACE) assay for detection of anti-drug antibody to monoclonal antibody therapeutics in the presence of high levels of drug.
    Bourdage JS; Cook CA; Farrington DL; Chain JS; Konrad RJ
    J Immunol Methods; 2007 Oct; 327(1-2):10-7. PubMed ID: 17716682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a homogeneous mobility shift assay for the measurement of infliximab and antibodies-to-infliximab levels in patient serum.
    Wang SL; Ohrmund L; Hauenstein S; Salbato J; Reddy R; Monk P; Lockton S; Ling N; Singh S
    J Immunol Methods; 2012 Aug; 382(1-2):177-88. PubMed ID: 22691619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of two ELISA methods to detect therapeutic anti-IGF1R antibodies in clinical study samples of dalotuzumab.
    Yin KC; Chen D; Bakhtiar R; Verch T
    Bioanalysis; 2011 Sep; 3(18):2107-17. PubMed ID: 21942521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of ELISAs for quantification of HMFG1-specific human anti-mouse IgG and IgM antibodies.
    Oei AL; Boerman OC; Geurts-Moespot A; van Eerd JE; van Tienoven D; Courtenay-Luck N; Thomas CM; Massuger LF; Sweep FC
    Int J Biol Markers; 2007; 22(3):167-71. PubMed ID: 17922458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.